Contact
Please use this form to send email to PR contact of this press release:
Cellectar Reports Positive Phase 2 Interim Data for CLR 131 in Relapsed/Refractory DLBCL Patients
TO:
Please use this form to send email to PR contact of this press release:
Cellectar Reports Positive Phase 2 Interim Data for CLR 131 in Relapsed/Refractory DLBCL Patients
TO: